Claim your company profile
AfterRaise/Weekly/Week 3, 2026

The AfterRaise week

Week 3, 2026

69 rounds, $6.0B of announced capital. The largest: Skild AI raised $1.4B. Sorted by size; every figure links to its source.

FundingPublic signal9 months ago
Skild AI
$1.4B · Growth · Pittsburgh, USA · Robotics & Manufacturing
What changed

Raised $1.4B in Growth funding, led by SoftBank Group.

The company said the funding supports continue scaling its model training and growing the future deployment of its technology across enterprise and commercial sectors.

Likely next AfterRaise intelligenceCommercial team build-outRevenue leadership appointmentsPlatform and infrastructure scaling
Where help may be relevant AfterRaise intelligenceEngineering hiringDistribution partnersIndustrial partnershipsRevenue leadershipChannel partners
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
Parloa
$350M · Series D · Berlin, Germany · AI & Data Infrastructure
What changed

Raised $350M in Series D funding, led by General Catalyst.

The company said the funding supports continue its global expansion focused on the U.S. and Europe, enhance its AI Agent Management Platform (AMP) with further industry-defining functionality, and launch the Parloa Promise, a commitment to preeminent agent reliability, relentless innovation, and human-centric responsible AI.

Likely next AfterRaise intelligenceGlobal market entryEuropean market entryUS market entry
Where help may be relevant AfterRaise intelligenceInfrastructure and computeData partnershipsProduct leadershipMarket-entry advisersLocal employment infrastructure
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
Mirador
$250M · Series B · San Diego, USA · Biotech & Pharma
What changed

Raised $250M in Series B funding.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligenceResearch programme expansionScientific team growthAggressive multi-front expansion
Where help may be relevant AfterRaise intelligenceClinical operationsScientific hiringScientific advisersResearch operationsSpecialist suppliers
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
Orca Bio
$250M · Undisclosed · Menlo Park, USA · Biotech & Pharma
What changed

Raised $250M.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligenceAggressive multi-front expansionSenior executive hiringOperational scale
Where help may be relevant AfterRaise intelligenceClinical operationsRegulatory affairsCMC and manufacturingQuality systemsMedical affairs
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
DC BLOX
$240M · Undisclosed · Atlanta, USA · AI & Data Infrastructure
What changed

Raised $240M.

The company said the funding supports its hyperscale data center expansion strategy across the Southeastern United States.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceInfrastructure and computeSecurity reviewData partnershipsMarket-entry advisersLocal employment infrastructure
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
Onebrief
$220M · Series D · Honululu, USA · Enterprise Software
What changed

Raised $220M in Series D funding.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligenceAggressive multi-front expansionSenior executive hiringMulti-market operations
Where help may be relevant AfterRaise intelligenceEnterprise salesCustomer successRevenue operationsSecurity and SOC 2Cloud infrastructure
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
Aspen Power
$200M · Undisclosed · NYC, USA · Energy & Climate
What changed

Raised $200M.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligenceProduct launches and new tiersProduct leadership hiringAggressive multi-front expansion
Where help may be relevant AfterRaise intelligenceGrid and utility partnershipsIndustrial partnershipsProduct leadershipDesign partnersSpecialist engineering
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
Harmattan AI
$200M · Series B · Paris, France · Defence, Space & Aerospace
What changed

Raised $200M in Series B funding, led by Dassault Aviation.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligenceAggressive multi-front expansionSenior executive hiringCommercial scale-up
Where help may be relevant AfterRaise intelligenceCertification and airworthinessGovernment relationsSecurity clearance hiringManufacturing scale-upSupply chain
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
AirNexis Therapeutics
$200M · Series A · Palo Alto, USA · Biotech & Pharma
What changed

Raised $200M in Series A funding.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligenceResearch programme expansionScientific team growthAggressive multi-front expansion
Where help may be relevant AfterRaise intelligenceClinical operationsScientific hiringScientific advisersResearch operationsSpecialist suppliers
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
JetZero
$175M · Series B · Long Beach, USA · Other
What changed

Raised $175M in Series B funding.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligenceCommercial team build-outRevenue leadership appointmentsManufacturing capacity expansion
Where help may be relevant AfterRaise intelligenceCertification and airworthinessSecurity clearance hiringManufacturing scale-upRevenue leadershipChannel partners
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
Alpaca
$150M · Series D · San Mateo, USA · Fintech & Insurance
What changed

Raised $150M in Series D funding, led by Drive Capital.

The company said the funding supports consolidate its global investment infrastructure in support of sophisticated financial institutions and institutional trading clients worldwide.

Likely next AfterRaise intelligenceProduct launches and new tiersProduct leadership hiringPlatform and infrastructure scaling
Where help may be relevant AfterRaise intelligenceBanking partnershipsData securityProduct leadershipDesign partnersSpecialist engineering
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
Torq
$140M · Series D · NYC, USA · AI & Data Infrastructure
What changed

Raised $140M in Series D funding.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligenceAggressive multi-front expansionSenior executive hiringMulti-market operations
Where help may be relevant AfterRaise intelligenceInfrastructure and computeAI governanceEnterprise salesSecurity reviewModel evaluation
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
MEDIPOST
$140M · Undisclosed · Cambridge, USA · Biotech & Pharma
What changed

Raised $140M.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligenceAggressive multi-front expansionSenior executive hiringOperational scale
Where help may be relevant AfterRaise intelligenceClinical operationsRegulatory affairsCMC and manufacturingQuality systemsMedical affairs
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
Defense Unicorns
$136M · Series B · San Antonio, USA · Defence, Space & Aerospace
What changed

Raised $136M in Series B funding.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligenceAggressive multi-front expansionSenior executive hiringCommercial scale-up
Where help may be relevant AfterRaise intelligenceCertification and airworthinessGovernment relationsSecurity clearance hiringManufacturing scale-upSupply chain
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
Deepgram
$130M · Series C · San Francisco, USA · AI & Data Infrastructure
What changed

Raised $130M in Series C funding.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligenceProduct launches and new tiersProduct leadership hiringAggressive multi-front expansion
Where help may be relevant AfterRaise intelligenceData partnershipsProduct leadershipDesign partnersSpecialist engineeringInfrastructure and compute
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
Tulip
$120M · Series D · Somerville, USA · Enterprise Software
What changed

Raised $120M in Series D funding, led by Mitsubishi Electric Corporation (TOKYO: 6503).

The company said the funding supports expand operations and its development efforts.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceCloud infrastructureChannel partnershipsMarket-entry advisersLocal employment infrastructureIn-market partnerships
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
Mytra
$120M · Series C · Brisbane, USA · Logistics & Mobility
What changed

Raised $120M in Series C funding, led by Avenir Growth.

The company said the funding supports accelerate deployment scaling to meet customer demand and fuel strategic talent acquisition.

Likely next AfterRaise intelligenceTeam growth across core functionsSenior leadership appointmentsManufacturing capacity expansion
Where help may be relevant AfterRaise intelligenceCarrier and network partnershipsInfrastructure partnershipsExecutive searchTalent partnersEmployer infrastructure
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
Kinaset Therapeutics
$103M · Series B · Boston, USA · Biotech & Pharma
What changed

Raised $103M in Series B funding.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligenceResearch programme expansionScientific team growthAggressive multi-front expansion
Where help may be relevant AfterRaise intelligenceClinical operationsScientific hiringScientific advisersResearch operationsSpecialist suppliers
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
osapiens
$100M · Series C · Mannheim, Germany · Energy & Climate
What changed

Raised $100M in Series C funding.

The company said the funding supports accelerate product innovation and accelerate growth in existing and new international markets, and consolidate its position as a global platform for sustainable growth.

Likely next AfterRaise intelligenceGlobal market entryNew market entryFirst local hires in the new market
Where help may be relevant AfterRaise intelligenceGrid and utility partnershipsProject financeIndustrial partnershipsMarket-entry advisersLocal employment infrastructure
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
Higgsfield
$80M · Series A · San Francisco, USA · Media & Creative
What changed

Raised $80M in Series A funding.

The company said the funding supports expand its API and marketing automation capabilities for customers building high-throughput marketing content systems.

Likely next AfterRaise intelligenceTeam growth across core functionsSenior leadership appointmentsNew market entry
Where help may be relevant AfterRaise intelligenceDistribution partnershipsBrand partnershipsExecutive searchTalent partnersEmployer infrastructure
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
Proxima
$80M · Seed · NYC, USA · Biotech & Pharma
What changed

Raised $80M in Seed funding.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligenceResearch programme expansionScientific team growthAccelerated hiring across functions
Where help may be relevant AfterRaise intelligenceClinical operationsScientific hiringScientific advisersResearch operationsSpecialist suppliers
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
Inquis Medical
$75M · Series C · Menlo Park, USA · Healthcare & Medtech
What changed

Raised $75M in Series C funding.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligenceAccelerated hiring across functionsMulti-market operationsExecutive appointments
Where help may be relevant AfterRaise intelligenceClinical evidenceRegulatory affairsReimbursement and market accessHospital procurement experienceQuality systems
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
Wasabi
$70M · Undisclosed · Boston, USA · Other
What changed

Raised $70M.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligencePlatform and infrastructure scalingInfrastructure hiringAccelerated hiring across functions
Where help may be relevant AfterRaise intelligenceGo-to-market partnershipsPlatform engineeringCloud and compute partnersSecurity reviewCommercial leadership
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
Accelsius
$65M · Series B · Austin, USA · Semiconductors & Hardware
What changed

Raised $65M in Series B funding.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligenceAccelerated hiring across functionsCommercial scale-upNew market preparation
Where help may be relevant AfterRaise intelligenceSupply chainFoundry and fabricationCertificationHardware engineeringProcurement
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
Vibrant Therapeutics
$61M · Undisclosed · USA · Biotech & Pharma
What changed

Raised $61M.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligenceAccelerated hiring across functionsOperational scaleMarket consolidation
Where help may be relevant AfterRaise intelligenceClinical operationsRegulatory affairsCMC and manufacturingQuality systemsMedical affairs
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
Aikido Security
$60M · Series B · UK · Other
What changed

Raised $60M in Series B funding, led by DST Global.

The company said the funding supports accelerate global expansion, and invest in engineering and go-to-market talent.

Likely next AfterRaise intelligenceGlobal market entryTeam growth across core functionsSenior leadership appointments
Where help may be relevant AfterRaise intelligenceCommercial leadershipOperations hiringGo-to-market partnershipsExecutive searchTalent partners
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
Cytotheryx
$60M · Series A · Rochester, USA · Biotech & Pharma
What changed

Raised $60M in Series A funding.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligenceResearch programme expansionScientific team growthAccelerated hiring across functions
Where help may be relevant AfterRaise intelligenceClinical operationsScientific hiringScientific advisersResearch operationsSpecialist suppliers
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
WitnessAI
$58M · Undisclosed · Mountain View, USA · Cybersecurity
What changed

Raised $58M.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligenceProduct launches and new tiersProduct leadership hiringAccelerated hiring across functions
Where help may be relevant AfterRaise intelligenceChannel partnershipsThreat intelligence partnershipsProduct leadershipDesign partnersSpecialist engineering
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
bit.bio
$50M · Undisclosed · Cambridge, UK · Biotech & Pharma
What changed

Raised $50M, led by M&G Investments.

The company said the funding supports accelerate the development of, and access to, its products, scale its operations globally, expand into the toxicology market, bolster its manufacturing operations, and generate new datasets for AI model training.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceCMC and manufacturingQuality systemsLicensing and BD partnershipsMarket-entry advisersLocal employment infrastructure
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
Positive Development
$45M · Debt · McLean, USA · Healthcare & Medtech
What changed

Raised $45M in Debt funding.

The company said the funding supports expand developmental therapy and autism diagnostics services into new and existing geographies across the United States, pursue strategic acquisitions, and increase access to care for families through health plans.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceProvider partnershipsMarket-entry advisersLocal employment infrastructureIn-market partnershipsCorporate finance advisers
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
VieCure
$43M · Undisclosed · Denver, USA · Biotech & Pharma
What changed

Raised $43M.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligenceProduct launches and new tiersProduct leadership hiringAccelerated hiring across functions
Where help may be relevant AfterRaise intelligenceLicensing and BD partnershipsProduct leadershipDesign partnersSpecialist engineeringClinical operations
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
WithCoverage
$42M · Series B · NYC, USA · Legal & Compliance
What changed

Raised $42M in Series B funding.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligenceProduct launches and new tiersProduct leadership hiringAccelerated hiring across functions
Where help may be relevant AfterRaise intelligenceProfessional services partnershipsProduct leadershipDesign partnersSpecialist engineeringEnterprise sales
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
depthfirst
$40M · Series A · San Francisco, USA · Other
What changed

Raised $40M in Series A funding, led by Accel.

The company said the funding supports support its research and development, GTM efforts, and hiring across applied research, engineering, product, and sales.

Likely next AfterRaise intelligenceAccelerated hiring across functionsCommercial scale-upNew market preparation
Where help may be relevant AfterRaise intelligenceInfrastructure and computeAI governanceEnterprise salesSecurity reviewModel evaluation
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
Midnite
$35M · Series C · London, UK · Consumer & Retail
What changed

Raised $35M in Series C funding, led by Raine Partners IV.

The company said the funding supports scale operations, accelerate development of products and support international expansion.

Likely next AfterRaise intelligenceGlobal market entryNew market entryFirst local hires in the new market
Where help may be relevant AfterRaise intelligenceRetail partnershipsBrand leadershipMarket-entry advisersLocal employment infrastructureIn-market partnerships
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
Juvena Therapeutics
$34M · Series B · Redwood City, USA · Biotech & Pharma
What changed

Raised $34M in Series B funding.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligenceResearch programme expansionScientific team growthAccelerated hiring across functions
Where help may be relevant AfterRaise intelligenceClinical operationsScientific hiringScientific advisersResearch operationsSpecialist suppliers
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
HPS/PayMedix
$33M · Debt · Milwaukee, USA · Healthcare & Medtech
What changed

Raised $33M in Debt funding.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligenceAccelerated hiring across functionsOperational scaleMarket consolidation
Where help may be relevant AfterRaise intelligenceClinical evidenceRegulatory affairsReimbursement and market accessHospital procurement experienceQuality systems
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
GovDash
$30M · Series B · NYC, USA · AI & Data Infrastructure
What changed

Raised $30M in Series B funding, led by Mucker Capital and British Columbia Investment Management Corporation (BCI).

The company said the funding supports expand its engineering teams across all product areas, invest in customer success, and grow its office presence in New York and Arlington, Virginia.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceInfrastructure and computeData partnershipsProduct leadershipMarket-entry advisersLocal employment infrastructure
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
Quadric
$30M · Series C · Burlingame, USA · Semiconductors & Hardware
What changed

Raised $30M in Series C funding, led by ACCELERATE Fund.

The company said the funding supports expand operations and its development efforts.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceIndustrial partnershipsMarket-entry advisersLocal employment infrastructureIn-market partnershipsSupply chain
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
Trybe
$30M · Series A · London, UK · Enterprise Software
What changed

Raised $30M in Series A funding.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligenceAccelerated hiring across functionsRepeatable go-to-market buildFirst senior commercial hires
Where help may be relevant AfterRaise intelligenceEnterprise salesCustomer successRevenue operationsSecurity and SOC 2Cloud infrastructure
Approach preferences not yet specified
Company pageSource
FundingPublic signal9 months ago
Ventaris Surgical
$30M · Series A · San Carlos, USA · Healthcare & Medtech
What changed

Raised $30M in Series A funding.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligenceAccelerated hiring across functionsRepeatable go-to-market buildFirst senior commercial hires
Where help may be relevant AfterRaise intelligenceClinical evidenceRegulatory affairsReimbursement and market accessHospital procurement experienceQuality systems
Approach preferences not yet specified
Company pageSource

The Daily Brief

This page, in your inbox.

Every disclosed US, UK and European round of $5M or more, with what each company said the money supports, the morning it is observed. One email, only on days something happened, unsubscribe with one click.